Discounted Cash Flow (DCF) Analysis Levered
Omega Healthcare Investors, Inc. (OHI)
$28.33
+0.23 (+0.82%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 881.68 | 928.83 | 892.38 | 1,062.81 | 878.24 | 885.17 | 892.16 | 899.19 | 906.29 | 913.44 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue (%) | ||||||||||
Operating Cash Flow | 499.37 | 553.75 | 708.26 | 722.14 | 625.73 | 592.74 | 597.42 | 602.13 | 606.88 | 611.67 |
Operating Cash Flow (%) | ||||||||||
Capital Expenditure | -139.44 | -139.68 | -75.11 | -95.06 | -105.86 | -106.70 | -107.54 | -108.39 | -109.24 | -110.10 |
Capital Expenditure (%) | ||||||||||
Free Cash Flow | 359.93 | 414.07 | 633.14 | 627.07 | 519.87 | 486.05 | 489.88 | 493.74 | 497.64 | 501.57 |
Weighted Average Cost Of Capital
Share price | $ 28.33 |
---|---|
Beta | 0.984 |
Diluted Shares Outstanding | 235.10 |
Cost of Debt | |
Tax Rate | 2.11 |
After-tax Cost of Debt | 1,120.45% |
Risk-Free Rate | |
Market Risk Premium | |
Cost of Equity | 8.454 |
Total Debt | 19.25 |
Total Equity | 6,660.50 |
Total Capital | 6,679.74 |
Debt Weighting | 0.29 |
Equity Weighting | 99.71 |
Wacc |
Build Up Free Cash Flow
Year A/P | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Actual | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected | 2027 Projected |
Revenue | 881.68 | 928.83 | 892.38 | 1,062.81 | 878.24 | 885.17 | 892.16 | 899.19 | 906.29 | 913.44 |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow | 499.37 | 553.75 | 708.26 | 722.14 | 625.73 | 592.74 | 597.42 | 602.13 | 606.88 | 611.67 |
Capital Expenditure | -139.44 | -139.68 | -75.11 | -95.06 | -105.86 | -106.70 | -107.54 | -108.39 | -109.24 | -110.10 |
Free Cash Flow | 359.93 | 414.07 | 633.14 | 627.07 | 519.87 | 486.05 | 489.88 | 493.74 | 497.64 | 501.57 |
WACC | ||||||||||
PV LFCF | 435.29 | 392.91 | 354.66 | 320.13 | 288.96 | |||||
SUM PV LFCF | 1,791.95 |
Terminal Value
Growth in perpetuity method: | |
---|---|
Long-term growth rate | |
WACC (%) | 11.66 |
Free cash flow (t + 1) | 511.60 |
Terminal Value | 5,296.03 |
Present Value of Terminal Value | 3,051.14 |
Intrinsic Value
Enterprise Value | 4,843.09 |
---|---|
Net Debt | -277.86 |
Equity Value | 5,120.95 |
Shares Outstanding | 235.10 |
Equity Value Per Share | 21.78 |